InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Peterson Kristine, Director. Director active across 2 companies, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 5 filings have been logged. Activity tracked since 16 February 2022. The latest transaction was disclosed on 30 November 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Peterson Kristine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
10,000 shares@ US$10.1040.2% of flowCommon StockSEC:0001415889-23-015908:0
59,000 sharesCommon StockSEC:0000899243-23-019363:0
10,000 shares@ US$14.7059.8% of flowCommon StockSEC:0001415889-23-013292:0
20,000 shares0Common StockSEC:0000904454-23-000107:0
20,000 shares0Common StockSEC:0000904454-22-000169:0
5 of 5 declarations
About Peterson Kristine
Peterson Kristine is Administrateur at Paratek Pharmaceuticals, Inc. and ImmunoGen, Inc. She has 5 filings in total, and within the sampled recent filings the period runs from 2022-02-18 to 2023-12-05, with transactions dominated by option exercise.
